- Investing Ideas
- /
- U.S. Undervalued Solid Performers
U.S. Undervalued Solid Performers
UPDATED Apr 10, 2024
Companies meeting several financial criteria and filtered from the entire market.
71 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$156.14 | 0.8% | 49.2% | US$2.0t | US$165.24 | PE26.3x | E11.8% | n/a | Media | ||
BRK.A | US$618,950.00 | -2.4% | 28.0% | US$897.0b | US$653,333.33 | PE9.3x | S1.3% | n/a | Diversified Financials | ||
COST | US$722.58 | 2.4% | 47.7% | US$318.7b | US$766.46 | PE47.2x | E7.4% | 0.6% | Consumer Retailing | ||
ADBE | US$487.22 | -2.0% | 31.7% | US$220.7b | US$617.38 | PE45.5x | E17.1% | n/a | Software | ||
INTU | US$628.36 | 0.9% | 44.4% | US$180.3b | US$693.63 | PE63.5x | E17.4% | 0.6% | Software | ||
VRTX | US$397.58 | -2.7% | 21.8% | US$104.5b | US$461.10 | PE28.4x | E11.2% | n/a | Pharmaceuticals & Biotech | ||
REGN | US$936.20 | -1.6% | 14.1% | US$101.4b | US$1,026.39 | PE25.4x | E10.9% | n/a | Pharmaceuticals & Biotech | ||
CB | US$248.00 | -2.7% | 24.5% | US$100.7b | US$265.57 | PE11.2x | E1.2% | 1.4% | Insurance | ||
NTES | US$99.50 | 2.8% | 13.0% | US$62.9b | US$134.40 | PE15.3x | E7.9% | 2.6% | Media | ||
LEN | US$156.43 | -5.8% | 48.4% | US$45.7b | US$178.05 | PE10.9x | E4.1% | 1.3% | Consumer Durables | ||
PAYX | US$124.52 | 3.5% | 14.9% | US$45.6b | US$121.06 | PE27x | E6.3% | 2.9% | Commercial Services | ||
VEEV | US$210.92 | -2.9% | 19.4% | US$34.9b | US$240.99 | PE64.7x | E17.0% | n/a | Healthcare | ||
ACGL | US$92.19 | -0.04% | 31.3% | US$34.1b | US$102.87 | PE7.8x | E-8.3% | n/a | Insurance | ||
FTV | US$83.23 | -1.8% | 24.5% | US$29.6b | US$90.41 | PE33.8x | E13.2% | 0.4% | Capital Goods | ||
RMD | US$193.80 | 4.2% | -12.8% | US$28.5b | US$206.05 | PE32x | E13.5% | 1.0% | Healthcare | ||
PHM | US$109.40 | -5.4% | 83.1% | US$24.3b | US$125.63 | PE8.9x | E-1.8% | 0.7% | Consumer Durables | ||
ULTA | US$450.95 | 2.5% | -13.8% | US$22.0b | US$568.98 | PE16.9x | E4.3% | n/a | Retail | ||
WRB | US$83.93 | -3.6% | 33.6% | US$21.5b | US$87.65 | PE15.6x | E6.6% | 0.5% | Insurance | ||
WSM | US$293.24 | -5.1% | 148.6% | US$19.9b | US$286.45 | PE19.8x | E3.6% | 1.5% | Retail | ||
ZM | US$62.22 | -1.6% | -7.8% | US$19.6b | US$78.66 | PE30x | E4.2% | n/a | Software | ||
MKL | US$1,490.09 | -0.3% | 12.2% | US$19.5b | US$1,450.83 | PE9.9x | E0.2% | n/a | Insurance | ||
PFG | US$81.27 | -5.2% | 7.9% | US$19.5b | US$83.36 | PE30.7x | E24.0% | 3.4% | Insurance | ||
RF | US$19.68 | -2.7% | 7.4% | US$19.0b | US$22.09 | PB1.1x | E1.3% | 4.9% | Banks | ||
NBIX | US$138.09 | 0.4% | 34.1% | US$13.8b | US$152.09 | PE55x | E26.6% | n/a | Pharmaceuticals & Biotech |